CSIMarket
 


Antares Pharma Inc   (ATRS)
Other Ticker:  
 
 

ATRS's Income from Cont. Operations Growth by Quarter and Year

Antares Pharma Inc 's Income from Cont. Operations results by quarter and year




ATRS Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 32.68 51.39 4.70
III Quarter September - 5.39 5.00 1.04
II Quarter June - 4.42 2.18 -2.23
I Quarter March -2.32 3.79 -2.36 -5.54
FY   -2.32 46.28 56.21 -2.03



ATRS Income from Cont. Operations first quarter 2022 Y/Y Growth Comment
Antares Pharma Inc in the first quarter 2022 recorded loss from continued operations of $ -2.32 millions.

According to the results reported in the first quarter 2022, Antares Pharma Inc achieved the best Income from Cont. Operations growth in Medical Equipment & Supplies industry. While Antares Pharma Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the first quarter 2022.




ATRS Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -36.41 % 993.4 % -23.33 %
III Quarter September - 7.8 % 380.77 % -
II Quarter June - 102.75 % - -
I Quarter March - - - -
FY   - -17.67 % - -

Financial Statements
Antares Pharma Inc 's first quarter 2022 Income from Cont. Operations $ -2.32 millions ATRS's Income Statement
Antares Pharma Inc 's first quarter 2021 Income from Cont. Operations $ 3.79 millions Quarterly ATRS's Income Statement
New: More ATRS's historic Income from Cont. Operations Growth >>


ATRS Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 506.31 % 927.8 % 351.92 %
III Quarter September - 21.95 % 129.36 % -
II Quarter June - 16.62 % - -
I Quarter March - -92.63 % - -
FY (Year on Year)   - -17.67 % - -




Income from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Antares Pharma Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRS's I. Quarter Q/Q Income from Cont. Operations Comment
I. Quarter 2022 accomplishment of -2.32 millions by Antares Pharma Inc look even less good if you take a look at 32.68 millions loss from continued operations in the fourth quarter.

Within Medical Equipment & Supplies industry Antares Pharma Inc achieved highest sequential Income from Cont. Operations growth. While Antares Pharma Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRS's I. Quarter Q/Q Income from Cont. Operations Comment
Current results of -2.32 millions by Antares Pharma Inc look even less good considering the loss from continued operations 32.68 millions in the previous quarter.

Within Medical Equipment & Supplies industry Antares Pharma Inc achieved highest sequential Income from Cont. Operations growth. While Antares Pharma Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Antares Pharma Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ 40.18 $ 46.29 $ 64.99 $ 64.60 $ 62.35
Y / Y Income from Cont. Operations Growth (TTM) -35.57 % -17.64 % 583.41 % 1062.41 % 5293.6 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 9 # 1723 # 111 # 43 # 9
Seqeuential Income from Cont. Operations Change (TTM) -13.21 % -28.78 % 0.61 % 3.6 % 10.94 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1917 # 2218 # 1596 # 1221 # 139




Cumulative Income from Cont. Operations growth Comment
Antares Pharma Inc 's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -35.57% year on year, at Mar 31 2022 compare to the -17.64% decrease at Dec 31 2021. If the Antares Pharma Inc 's fiscal year would end at Mar 31 2022, annual Income from Cont. Operations would be $40 millions.

Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 9, from total ranking in previous quarter at 1723.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
490.97 %
84.45 %
-28.78 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 34
Healthcare Sector # 2
Overall # 9

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
5293.6 %
1377.24 %
-35.57 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 144
S&P 500 # 1917
Cumulative Income from Cont. Operations growth Comment
Antares Pharma Inc 's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -35.57% year on year, at Mar 31 2022 compare to the -17.64% decrease at Dec 31 2021. If the Antares Pharma Inc 's fiscal year would end at Mar 31 2022, annual Income from Cont. Operations would be $40 millions.

Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 9, from total ranking in previous quarter at 1723.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
490.97 %
84.45 %
-28.78 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 34
Healthcare Sector # 2
Overall # 9

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
5293.6 %
1377.24 %
-35.57 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 144
S&P 500 # 1917




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
ATRS's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for ATRS's Competitors
Income from Cont. Operations Growth for Antares Pharma Inc 's Suppliers
Income from Cont. Operations Growth for ATRS's Customers

You may also want to know
ATRS's Annual Growth Rates ATRS's Profitability Ratios ATRS's Asset Turnover Ratio ATRS's Dividend Growth
ATRS's Roe ATRS's Valuation Ratios ATRS's Financial Strength Ratios ATRS's Dividend Payout Ratio
ATRS's Roa ATRS's Inventory Turnover Ratio ATRS's Growth Rates ATRS's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2022
Chemed Corporation-1.88%$ -1.882 millions
Biomx Inc -2.77%$ -2.773 millions
Ironwood Pharmaceuticals inc -2.82%$ -2.818 millions
Corcept Therapeutics Inc-2.85%$ -2.847 millions
Msa Safety Incorporated-2.89%$ -2.891 millions
Merit Medical Systems Inc-3.77%$ -3.769 millions
Addus Homecare Corporation-4.77%$ -4.767 millions
Idexx Laboratories Inc-5.05%$ -5.054 millions
Hca Healthcare Inc -7.28%$ -7.278 millions
National Research Corporation-7.51%$ -7.506 millions
Amgen Inc -10.33%$ -10.328 millions
Organon and Co -11.90%$ -11.899 millions
Regeneron Pharmaceuticals Inc -12.71%$ -12.706 millions
Blueriver Acquisition Corp -14.64%$ -14.638 millions
Intuitive Surgical Inc -15.12%$ -15.119 millions
Globus Medical Inc -15.98%$ -15.983 millions
Encompass Health Corporation-17.09%$ -17.093 millions
Molecular Templates inc -19.30%$ -19.296 millions
Royalty Pharma Plc-19.43%$ -19.434 millions
3m Company-19.91%$ -19.914 millions
Natus Medical Inc-20.58%$ -20.576 millions
Fulgent Genetics Inc -23.49%$ -23.486 millions
Quest Diagnostics Inc-23.88%$ -23.878 millions
Fonar Corporation-24.12%$ -24.122 millions
Hologic Inc-26.49%$ -26.488 millions
Integra Lifesciences Holdings Corp-27.52%$ -27.521 millions
Universal Health Services Inc -27.77%$ -27.765 millions
National Healthcare Corp-27.97%$ -27.966 millions
Incyte Corporation-29.03%$ -29.033 millions
Davita Inc -29.44%$ -29.439 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com